This study evaluates the biocompatibility and photocatalytic properties of ZnO-rGO nanocomposite, suggesting potential in environmental remediation.
This study explores a green synthesis approach for creating a nanocomposite material consisting of zinc oxide (ZnO) nanoparticles decorated with reduced graphene oxide (rGO), utilizing Clitoria ternatea flower extract as a biogenic reducing agent. The objective was to leverage the phytochemicals present in the flower extract to form ZnO nanoparticles, enhance their properties through rGO integration, and evaluate their structural and photocatalytic characteristics. The nanocomposite was characterized using a comprehensive suite of techniques, including XRD, FTIR, UV–Vis spectroscopy, DLS, zeta potential, SEM, and EDAX. To assess the in vitro biocompatibility, an MTT assay was performed on the normal fibroblast cell line 3T3L1. The nanocomposite exhibited minimal cytotoxicity with over 86% cell viability at concentrations up to 320 μg/mL. Additionally, hemolysis assays demonstrated that the nanocomposite induced less than 5% hemolysis, indicating excellent hemocompatibility. In an in vivo evaluation, zebrafish embryos exhibited no deformities, and the cumulative hatchability was also not affected up to a dose of 50 μg/mL. The exploration of environmental remediation was studied using bromophenol dye degradation, which showed a 65% dye degradation within 30 min of exposure to the composite and sunlight. The outcome of the study showed successful formation of ZnO and its composite with rGO (CT-rGO-ZnO), exhibiting excellent biocompatibility and improved photocatalytic properties. The material demonstrates promise for applications in environmental remediation and energy-related fields. The environmentally friendly nature of the synthesis approach also makes it a valuable contribution toward sustainable nanotechnology.
No takes yet. Share an insight, caveat, or question.
Guttapalli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: